MOLECULAR CELLULAR BIOLOGY, June 1998, p. 3191â€“3200                                                                          Vol. 18,  6
0270-7306/98/$04.0010
Copyright Â© 1998, American Society Microbiology



               Chimeric Subunit Yeast Transcription Factor IIIC
                          Forms Subcomplex t95
        NATHALIE MANAUD, ROSALI ARREBOLA,                                              Â´ NE
                                                Â´ DICTE BUFFIN-MEYER, OLIVIER LEFEBVRE,
             HARTMUT VOSS,â€  MICHEL RIVA, CHRISTINE CONESA, ANDRE Â´ SENTENAC*
                Service Biochimie et GeÂ´neÂ´tique MoleÂ´culaire, CEA/Saclay, F-91191 Gif-sur-Yvette Cedex, France
                       Received 20 January 1998/Returned modification 25 February 1998/Accepted 5 March 1998

             multisubunit yeast transcription factor IIIC (TFIIIC) multifunctional protein required promoter
          recognition, transcription factor IIIB recruitment, chromatin antirepression. report isolation           characterization TFC7, essential gene encoding 55-kDa polypeptide, t55, present affinity-purified
          TFIIIC. t55 chimeric protein generated ancient chromosomal rearrangement. C-terminal half           essential cell viability sufficient ensure TFIIIC function DNA binding transcription assays.
          N-terminal half nonessential highly similar putative yeast protein encoded           chromosome cyanobacterial protein unknown function. Partial deletions N-terminal domain
          impaired t55 function high temperature media containing glycerol ethanol, suggesting link
          PolIII transcription metabolic pathways. Interestingly, t55  TFIIIC
          subunit t95, protein complex distinct TFIIIC play role regulation
          PolIII transcription, possibly relation cell metabolism.


   eucaryotic cells, transcription variety small                  molecular structure yeast TFIIIB TFIIIC genes conducted RNA polymerase III (PolIII)                      investigated. Yeast TFIIIB comprises com-
quires auxiliary factors. yeast tRNA gene (tDNA)                  ponents: TBP, TATA box binding protein, activation, preinitiation complexes assembled defined                required transcription PolI PolII, additional
order upstream transcription unit (18, 27,                  polypeptides, TFIIIB70/BRF1 TFIIIB90/B0, iden-
52). Transcription factor IIIC (TFIIIC) plays primary role               tified protein-DNA cross-linking (6). TBP, multistep complex assembly binding intragenic                  TFIIIB70 able bind TFIIIC-tDNA complexes (29). promoter elements tRNA genes  B blocks). Yeast                   resulting complex competent recruit PolIII TFIIIC remarkably large multisubunit factor                  assembly TFIIIB90 (29, 30). Purified yeast TFIIIC com-
protein subassemblies, named tA tB, distinct                    prises polypeptides, 138, 131, 95, 91, 60, 55 kDa (5,
DNA binding properties, visualized electron                    16, 43). Purification TFIIIC near homogeneity, protein-
microscopy free DNA-bound form (46),                  DNA cross-linking (5, 9, 16), coimmunoprecipitation ex-
cleaved limited proteolysis (37). tB domain binds
                                                                              periments (13, 44) suggested largest polypeptides
tightly B block (37) shown display                                                                               subunits TFIIIC, suggestion confirmed properties enhancer binding proteins (11). Binding                                                                               gene cloning (2, 34, 36, 44, 48). 138- 95-kDa compo-
tA domain block weaker B block
dependent. bound, TFIIIC promotes binding tran-                   nents (t138 t95), located tB tA, respectively, scription factor IIIB (TFIIIB) upstream transcription                  thought DNA binding subunits, start site (6, 26, 28, 31). process similar yeast 5S               specifically cross-linked tDNA probe mapped RNA gene activation, TFIIIC assembly depen-                    level B block block, respectively (5, 9, 13,
dent binding transcription factor IIIA (TFIIIA)                16). t91 recently shown cooperate t138 TFIIIC- internal promoter sequence. TFIIIB itself does bind                tDNA binding (2) mapped 39 location detectably TATA PolIII genes  assembled                  TFIIIC-5S RNA gene complexes (9). t131 stands TFIIIC, interacts intimately DNA sufficient,             TFIIIB-assembling subunit based upstream gene loca- yeast  directing accurate initiation PolIII              tion, shown protein-DNA cross-linking (5, 6), direct multiple rounds transcription vitro (28, 31).                    interaction TFIIIB70 TFIIIB90 (12, 32, 45).  TFIIIB initiation factor required activa-               hand, little known smallest polypeptides,
tion PolIII genes, TFIIIC TFIIIA act                    60 55 kDa, reproducibly copurify yeast
assembly factors.  shown TFIIIC                 TFIIIC activity. proteins multifunctional protein, involved promoter recog-                 polypeptides isolated TFIIIC-tDNA complexes (16). nition TFIIIB recruitment displacement                 55-kDa polypeptide located photo-cross-linking exper-
nucleosomes relieve repression transcription chro-               iments t95, opposite sides DNA helix,
matin (10).                                                                   vicinity block tRNA genes (5, 6). 60-kDa
                                                                              polypeptide cross-linked DNA.
                                                                                 report cloning identification TFC7,   * Corresponding author. Mailing address: Service Biochimie et            essential gene encoding 55-kDa subunit TFIIIC. Anal- GeÂ´neÂ´tique MoleÂ´culaire, CEA/Saclay, F-91191 Gif-sur-Yvette Ce-
dex, France. Phone: 33 1 69 08 22 36. Fax: 33 1 69 08 47 12. E-mail:
                                                                              ysis deletion mutants showed C-terminal half
sentenac@dsvidf.cea.fr.                                                       t55 necessary TFIIIC transcriptional activity.   â€  Present address: LION Biosciences AG, 69120 Heidelberg, Ger-              t55 interacts t95 subunits                                                                          present distinct protein complexes.

                                                                       3191
 3192       MANAUD ET AL.                                                                                                                           MOL. CELL. BIOL.


                         MATERIALS METHODS                                         oligonucleotides, NM8 (59-TCCTTTTCAATACATATGTATCCTTACGACGTT
                                                                                       CCTGATTATGCCATGGTGGTGAACAC) NM7 (59-TCAGCGGGATCCT
   Yeast strains methods. YNN281 3 YNN282 (22) used gene                   TACATAGGGCGGACATTGC), used mutagenesis. NM8 contains disruption. Preparation media, tetrad dissection, yeast methods           epitope coding sequence (boldface letters) nucleotides com- performed standard techniques (3). Plasmids harboring modified alleles         plementary TFC7 DNA create NdeI NcoI restriction sites. NM7 TFC7 gene used transform YNM2 haploid strain (ade2-101              complementary TFC7 harbors BamHI restriction site (boldfaced) just
lys2-801 ura3-52 trp1-D1 his3-D200 tfc7-D::HIS3 pNM2). modified copies          stop codon. amplified DNA fragment cloned pGEM-T
TFC7 substituted wild-type TFC7 plasmid shuffling plates            vector (Promega), creating pNM8. NdeI/BamHI NcoI/BamHI fragments
taining 5-fluoro-orotic acid. Viable strains isolated 30Â°C tested     pNM8 cloned pET28a (Novagen), pAS2, pACT2 (21),
growth 37 16Â°C.                                                                 creating pNM11, pAS-t55, pACT-t55, respectively.
   Purification immunoprecipitation TFIIIC. TFIIIC purified starting           NdeI restriction site inserted TFC7 gene promoter PCR- 30 g (wet weight) Saccharomyces cerevisiae cells following procedure       mediated mutagenesis plasmid pNM2 oligonucleotides NM5 (59-CA
described Huet et al. (25). Immunoprecipitation performed described          GCCATTGACCCCAAAATGAGAA) NM9 (59-CGTGTTCACCACCAT Ossipow et al. (39). Cells expressing wild-type epitope-tagged versions       ATGTATTGAAAAGGA). resulting PCR product cloned t138, t131, t95 (25, 34, 36) harvested exponential phase, crude     pGEM-T vector, creating pNM10. SphI/NdeI fragment pNM10 extracts prepared described Huet et al. (25), protease          NdeI/BamHI fragment pNM8 sequentially cloned YCplac22 (19),
inhibitors (O-complete; Boehringer) extraction buffer containing 20 mM             creating pNM12. t55-DN1, t55-DN2, t55-DN3, t55-DC mutants HEPES (pH 7.5), 50 mM CH3COOK, 1 mM EDTA, 1 mM dithiothreitol (DTT),                   constructed deletions nucleotides 49 288, 286 834, 34 834, 835 10  glycerol used. Proteins precipitated ammonium sulfate,          1335, respectively, epitope-tagged version TFC7. mutants resuspended 5  original crude extract volume dialysis buffer (25 mM       obtained cleavage pNM8 BsaBI/XbaI, XbaI/EcoRV, StyI/EcoRV, HEPES [pH 7.5], 100 mM KCl, 0.1 mM EDTA, 0.25 mM DTT, 10  glycerol),                   EcoRV/BamHI, respectively, treatment Klenow DNA polymerase mung dialyzed twice 2 h time 4Â°C 250 volumes            bean nuclease, religation, sequencing junction. resulting NdeI/
buffer. Typically, 10 g (wet weight) yeast cells yielded 2 ml dialyzed extract   BamHI DNA fragments cloned pNM12, place wild-type
containing 15 30 mg protein/ml, estimated Bradford analysis (8).       tagged version TFC7, creating pNM24, pNM25, pNM26, pNM15, respec-
assay, 1.2 mg mouse monoclonal antihemagglutinin (HA) antibodies (53)           tively. EcoRI/SalI DNA fragments pNM12, pNM15, pNM24, pNM25,
incubated 30 min 10Â°C 20 ml magnetic beads (8 3 108 beads/ml         pNM26 cloned pUN45 used transform YNM2 yeast cells.
phosphate-buffered saline containing 0.1  bovine serum albumin [BSA]) coated              Expression TFC7 Escherichia coli. Recombinant TFC7 protein (rTFC7p) rat monoclonal antibodies directed mouse immunoglobulin G2b               tagged N-terminal end histidines HA epitope (Dynal M450). extensive washing phosphate-buffered saline containing          expressed plasmid pNM11 E. coli BL21(pLysS). Crude extract prepara-
0.1  BSA dialysis buffer, beads incubated gentle             tion protein purification Ni21-nitrilotriacetic acid (NTA)â€“agarose (Qia-
shaking 10Â°C 50 ml dialyzed extract. 3 h incubation, beads     gen) native conditions performed described Chaussivert et al. washed times 200 ml washing buffer (25 mM HEPES [pH 7.5],           (12).
50 mM KCl, 0.1 mM EDTA, 10  glycerol, 0.1  Triton X-100). Proteins                   Anti-t55, -t95, -t131 polyclonal antibodies. rTFC7p recombinant
eluted incubation 30 min room temperature 16 ml washing buffer       t131DTPR2 (12) expressed hexahistidine fusions, purified Ni21-
containing 2 mg synthetic peptide corresponding HA sequence ml.        NTAâ€“agarose, loaded preparative SDSâ€“8  polyacrylamide gel. Gel
Immunoprecipitated proteins analyzed sodium dodecyl sulfate (SDS)-             slices containing recombinant t55 t131 derivatives 95-kDa subunit
polyacrylamide gel electrophoresis (PAGE) Western blotting.                        preparative SDS-polyacrylamide gel used t55 amino acid se-
   Amino acid sequence determination. TFIIIC purified preparative             quence determination   excised injected rabbits  scale following immunopurification procedure described Huet et al. (25).        injections 3-week intervals) production antibodies. Preimmune
Affinity-purified fractions containing TFIIIC DNA binding activity pooled         antibodies antibodies directed TFIIIC subunits purified protein
(133 fractions, 66.5-ml final volume). Proteins precipitated cold tri-       Sepharose described previously (20), protein concentration chloroacetic acid (10  final concentration) 40 min ice centrifuged       estimated Bradford analysis (8).
4Â°C 4 h 17,600 3g. Pellets washed cold acetone, centrifuged (4Â°C,        Interaction t55 35S-labeled t95. Far-Western experiments 
20 min, 17,600 3 g, resuspended 0.6 ml SDS electrophoresis buffer (3).       formed described previously (24), rTFC7p denatured-rena-
Proteins separated electrophoresis overnight 8  polyacryl-          tured filters incubation labeled probe. Plasmid pCS5, harbor-
amideâ€“SDS gel slightly stained Coomassie blue. Polypeptides 138,           ing TFC1 gene encoding t95 (48), linearized StuI. gene 131, 95, 91, 80, 75, 60, 55, 50 kDa revealed. Starting 880 g (wet        transcribed vitro T7 RNA polymerase wheat germ extracts (Promega)
weight) YCS7 cells expressing HA-tagged version t95 (25), 200        presence [35S]methionine. Recombinant t55 subjected SDS-
250 pmol TFIIIC obtained. gel slice containing 95-kDa subunit         PAGE, blotted nitrocellulose, denatured-renatured according used anti-t95 production  . gel slice containing 55-kDa            method Papavassiliou Bohmann (42). filters incubated                                                                                        35
polypeptide excised, crushed, incubated protease described              S-labeled t95, washed, autoradiographed. Recombinant t55 located previously (48), proteinase K used instead trypsin.          use anti-HA antibodies, immune complexes visualized ECL
sulting peptides separated reversed-phase high-pressure liquid chroma-         kit (Amersham).
tography sequenced. Seven peptide sequences (YDNPRM, EIPVY, TYIPF,                    hybrid assays. expression GAL4(1-147)-t55 GAL4(768-881)-
ELAFPN, ERLVGT, FASPF, SDRKWV) determined.                                    t55 fusion proteins plasmids pAS-t55 pACT-t55, respectively,    Cloning disruption TFC7. degenerate oligonucleotides (Ol20               verified Western blot analysis yeast crude extracts polyclonal antibod-
[59CGGAATTCRTTNGGRAANGCNARYTC] Ol8 [59NNTAYGAYAA                                   ies directed GAL4. GAL1-LacZ activation assays performed YCCNMGNATG]) designed peptides ELAFPN YDNPRM, respec-                         described previously (12) transformation yeast strain combinations
tively, used amplify yeast genomic DNA fragment â€œtouchdownâ€?               plasmids. Transcriptional activation lacZ reporter gene assayed PCR (14). 509-bp DNA fragment obtained, cloned pBSKS (Strat-                growing transformed cells selective medium overlaying agene), sequenced, contain continuous open reading frame                5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (X-Gal) agar. b-Galactosi-
(ORF) encoding initial peptides plus  sequence         dase activity yeast extracts measured exactly described previously (51),
entire TFC7 gene searching Munich Information Centre              30Â°C independent transformants. interaction Protein Sequences (MIPS) database (GenBank accession  Z75018).                      TFIIIB70 t131 (12) used reference.
   Disruption TFC7 gene performed PCR method (7).                     DNA binding transcription assays. transcription factor-tDNA inter-
57-mer oligonucleotides harboring sequences complementary TFC7 gene             action monitored gel retardation assay essentially described previ- yeast HIS3 selectable marker used amplify PCR '1.1-kb         ously (35). TFIIIC partially purified wild-type mutant crude extracts
DNA fragment directly introduced yeast YNN281 3 YNN282               chromatography Ultrogel-heparin A4R (Sepracor) column described
strain transformation. resulting His1 transformants, copy         previously (25). Heparin-purified TFIIIC fractions (1 ml, '0.5 mg protein) TFC7 ORF replaced HIS3 gene, surrounded stop codon                 incubated 32P-labeled DNA probe (3 10 fmol; 3,000 10,000
modules, inserted antisense direction respect TFC7. Diploid         cpm) 15 ml binding buffer containing 10 mM Tris-HCl (pH 8), 1 mM EDTA,
transformants verified PCR analysis. heterozygous diploid strain           150 mM KCl, 10  glycerol, 50 mg BSA, 1 mg competitor DNA. transformed multicopy plasmid pNM2 harboring TFC7                probe 200-bp PCR-amplified fragment plasmid pUC-Glu (17), car-
sporulated. spore bearing chromosomally deleted allele TFC7             rying yeast tRNAGlu3   gene, 200-bp PCR-amplified fragment plasmid
containing pNM2 plasmid chosen yield strain YNM2 used plasmid           pGE2 (4), harboring B block yeast tRNALeu      3   gene. Complexes
shuffling.                                                                             analyzed nondenaturing gel electrophoresis revealed autoradiog-
   Construction plasmids. 2.6-kb EcoRI/KpnI DNA fragment cos-              raphy (25).
mid cospEOA273 containing coding flanking sequences TFC7                   Transcription assays performed different templates: pUC-Glu
cloned plasmid YEplac195 (19), creating pNM2. sequence encoding             (17), harboring tRNAGlu  3   gene; pRS316-SUP4, containing yeast SUP4
methionine residue followed YPYDVPDYA epitope (HA epitope)                   tRNA gene  gift S. Shaaban); pGE2 (4), harboring yeast
                                                                                               Leu
rived influenza virus HA protein (53) added just initi-        tRNA3 gene. Transcription reactions carried 45 min 25Â°C ation codon TFC7 PCR-mediated mutagenesis plasmid pNM2.                   40-ml mixtures containing 20 mM HEPES-KOH (pH 7.9); 10  glycerol; 5 mM
 VOL. 18, 1998                                                                TFC7 ENCODES 55-kDa SUBUNIT YEAST TFIIIC                                  3193




   FIG. 1. Sequence analysis TFC7.   Schematic representation duplication block 50 defined Wolfe Shields (54). locations chromosomes XIV XV duplicated genes (TFC7 HUF) indicated shading. (B) regions sequence similarities TFC7p, HUFp, Syn H schematically
represented. (C) Sequence similarities TFC7p. N-terminal TFC7p (amino acids 1 278) aligned following protein sequences: HUFp, S.
cerevisiae 30.7-kDa hypothetical protein; Syn H, Synechocystis hypothetical protein; PGM, S. cerevisiae PGM; FbPase, S. cerevisiae FbPase; Cob C, S. typhimurium ribazole-59-phosphate phosphatase (GenBank accession  Z75018, Z71385, D64002, P00950, S42124, U12808, respectively). Complete sequences shown Syn H PGM. flanking portions proteins, showed homology TFC7p, included. amino acid positions sequence indicated right. Identical residues boxed, conserved substitutions shaded. Conserved active-site residues PGM, FbPase, Cob
C enzymes indicated stars.



MgCl2; 90 mM KCl; 0.1 mM EDTA; 1 mM DTT; 1 U RNasin (Amersham);                  elution step DNA affinity column. fraction 
0.6 mM ATP, GTP, CTP; 0.03 mM [32P]UTP (2 10 Ci/mmol); 0.1 mg           taining 50- 80-kDa polypeptides RNase activity plasmid DNA; heparin-purified TFIIIC fraction (1 ml, '0.5 mg); RNA PolIII
(50 ng); recombinant TFIIIB70 (150 ng); recombinant TBP (40 ng); B0             did explore 
fraction (400 ng). Protein fractions prepared according method          55-kDa polypeptide excised gel, 
Huet et al. (25). RNA transcripts analyzed polyacrylamide-urea gel          eral peptides obtained proteinase K digestion. electrophoresis revealed autoradiography (25).
   Nucleotide sequence accession number. GenBank accession number                                                                                     amino acid sequences seven peptides determined. 
TFC7 Z75018.                                                                     generate oligonucleotides designed amino acid se-
                                                                                    quences peptides used primers amplify                                                                                     genomic DNA fragment â€œtouchdownâ€? PCR (14). 509-bp
                                RESULTS
                                                                                    DNA fragment obtained contain continu-
   Isolation disruption TFC7 gene. Yeast TFIIIC                       ous ORF encoded peptides. stage, multisubunit protein comprises polypeptides, 138,                     sequence entire gene, named TFC7, ob-
131, 95, 91, 60, 55 kDa. order clone gene encod-                      tained MIPS database (GenBank accession 
ing 55-kDa subunit, TFIIIC purified preparative                        Z75018). TFC7 gene located chromosome XV.
scale crude extracts immunoaffinity DNA af-                             TFC7 ORF encodes 435-amino-acid protein finity purification procedure (25). TFIIIC components                          predicted Mr 49,000 theoretical pI 5 separated preparative SDS-PAGE stained Coo-                             contains seven microsequenced peptides. Comparison massie blue. TFIIIC fraction contained polypep-                         TFC7 protein (TFC7p) sequence National Center
tides consistently affinity-purified fractions plus                  Biotechnology Information (NCBI) nonredundant data-
additional polypeptides, 80, 75, 50 kDa. 75-kDa                          base use BLAST program server (1) revealed intrigu-
polypeptide, occasionally purified TFIIIC fractions,                       ing similarities N-terminal half TFC7p recently shown immunologically related 91-                         proteins unrelated transcription.  N-terminal
kDa protein (2). 80- 50-kDa polypeptides                         domain TFC7p shows 64  identity 80  similarity (Fig. contaminants easily separated TFIIIC                         1C) S. cerevisiae 30.7-kDa protein unknown function linear gradient ammonium sulfate instead salt                        encoded gene located chromosome XIV  3194     MANAUD ET AL.                                                                                                        MOL. CELL. BIOL.


provisionally named HUF  homolog unknown function). appears TFC7 HUF genes large blocks gene duplication chromosomes XIV XV. shown Fig. 1A, TFC7 HUF genes located just border duplication block 50, defined Wolfe Shields (54). coding sequence N-termi-
nal TFC7p belongs duplication block 50, coding sequence C-terminal half present chromosome XV.
   N-terminal TFC7p shows regions se-
quence similarity (Fig. 1B C) Synechocystis 23.7-kDa
protein (Syn H), unknown function, family phosphoglycerate mutase (PGM), fructose-2,6-bi-
phosphatase (FbPase), acid phosphatase enzymes various species. enzymes catalyze similar phosphotrans-
fer reactions involve phosphohistidine intermediate. activity shown dependent highly
conserved histidinyl residues arginyl residue (refer-
ence 40 references . Figure 1C shows compari-
son TFC7p N-terminal half, HUF protein (HUFp), Syn
H sequences sequences PGM FbPase enzymes S. cerevisiae Cob C acid phosphatase Sal-
monella typhimurium. TFC7p N-terminal moiety showed                 FIG. 2. TFC7 encodes subunit TFIIIC. TFIIIC purified heparin
approximately 20  identity 40  similarity amino           chromatography assayed gel retardation labeled tDNAGlu
                                                                                                                                        3   probe.
                                                                     Preformed TFIIIC-tDNAGlu    complexes (lane 1) incubated 250 500
acid sequence level PGM Cob C enzymes                                        3
                                                                     ng preimmune antibodies (lanes 4 5) anti-rTFC7p antibodies (lanes 2
15  identity 30  similarity FbPase enzyme).           3). Complexes separated nondenaturing electrophoresis  highly conserved catalytic residues amino       vealed autoradiography. C1, position TFIIIC-tDNA complexes; C2, posi-
acids flanking histidinyl residues conserved TFC7p.      tion complexes bound anti-rTFC7p antibodies; F, free labeled tDNA. sequence similarities proteins clearly unrelated transcription cyanobacterial protein raised ques-
tion functional role TFC7p,  PolIII transcrip-   DNA affinity-purified TFIIIC fraction (data shown).
tion. hand, similarity existing sequences      order investigate TFC7p TFIIIC
databases C-terminal half TFC7p,           subunits, purified anti-rTFC7p antibodies used alter included duplication block 50 (Fig. 1A).             migration TFIIIC-tDNA complexes mobility shift
   test TFC7 essential cell growth         assays (16, 48). Preformed TFIIIC-tDNAGlu    3   complexes bility, DNA fragment harboring yeast HIS3 gene sur-            incubated polyclonal anti-rTFC7p antibodies  preim-
rounded stop codons inserted place            mune control immunoglobulins) analyzed electro-
TFC7 ORF PCR method (7). resulting diploid cells            phoresis polyacrylamide gel. shown Fig. 2, anti-
(YNM1 strain) chromosomal copies               rTFC7p antibodies able bind TFIIIC-tDNA
TFC7 gene deleted. Analysis sporulation products           complexes (C1), converting larger species (C2)
vealed nonviable viable  his2) spores         migrated slowly (lanes 2 3). hand,
tetrad, showing TFC7 essential gene. confirm          migration TFIIIC-tDNA complexes affected result, strain YNM1 transformed multicopy plas-        preimmune antibodies (Fig. 2, lanes 4 5). supershift
mid pNM2, harboring TFC7, sporulated. resulting              induced anti-rTFC7p antibodies showed TFC7p haploid strain chromosomal disruption expressing          TFIIIC-tDNA complexes corresponds t55. plasmidic TFC7 gene viable.  TFC7, like                Analysis t55 mutants. similarity N-terminal
genes encoding largest subunits TFIIIC, essen-       half TFC7p cyanobacterial protein enzymes 
tial cell viability. hand, HUF,       lated glycolytic pathway intriguing. define t55 homolog unknown function TFC7 gene,                domains necessary TFIIIC activity, N-terminal
expressed essential cell viability (results      C-terminal deletions (Fig. 3A) HA-tagged version shown).                                                              t55 generated described Materials Methods.
   TFC7 encodes 55-kDa subunit TFIIIC. TFC7               Centromeric plasmids harboring mutant copies TFC7
gene engineered add histidine residues             gene tested ability functionally replace epitope derived influenza virus HA protein (HA              chromosomally disrupted copy TFC7. resulting strains
epitope) N terminus protein. tagged protein        grown different temperatures medium containing expressed E. coli cells purified histidine fusion    glucose glycerol carbon source. shown Fig. nondenaturing conditions Ni21-NTAâ€“agarose. West-            3A, deletion C-terminal domain (t55-DC) lethal,
ern blot analysis purified protein fraction performed     suggesting domain essential TFIIIC function. monoclonal antibodies directed HA epitope.          contrast, deletion N-terminal domain (t55-DN3), HA-tagged recombinant protein (predicted Mr, 50,000)             homologous HUFp, resulted wild-type phenotype (Fig.
migrated SDS-polyacrylamide gel apparent size          3B). vivo result confirmed vitro studies. '56 kDa, suggesting TFC7p posttranslationally         Wild-type t55-DN3 TFIIIC factors purified hep-
modified.                                                            arin chromatography tested tDNA binding activity    rTFC7p injected rabbits antibody production.         gel retardation assays ability promote tran-
Immunoblotting performed immune serum raised            scription different templates presence TFIIIB rTFC7p specifically revealed 55-kDa polypeptide present          RNA PolIII. Figure 4A shows deletion form TFIIIC
 VOL. 18, 1998                                                                   TFC7 ENCODES 55-kDa SUBUNIT YEAST TFIIIC                                     3195




   FIG. 3. Deletion analysis t55.   Deletion mutants constructed described Materials Methods HA-tagged version t55 (t55-WT).
t55-WT t55 deletions schematically represented. positions deleted amino acids (inclusive) construct indicated parentheses. Centromeric
plasmids harboring deletion mutant copy TFC7, expressed promoter, tested ability functionally replace, different temperatures glucose (Glu)- glycerol (Gly)-containing medium, chromosomally disrupted copy TFC7. summary viability thermal sensitivity strains shown; lethal (2), wild-type (1), temperature-sensitive (ts) phenotypes indicated; ND, determined. (B) Viability thermal sensitivity yeast strains harboring wild-type t55 deletion variants t55. Growth 30 37Â°C glucose- glycerol-containing medium wild-type viable t55 deletion
strains shown.


 able form complex tRNAGlu      3  gene.                           PolIII. shown Fig. 4B, using migration TFIIIC-tDNAGlu 3    complexes formed                          TFIIIC (based 95-kDa subunit), deletion form altered anti-HA antibodies, showing epitope-tagged                              TFIIIC showed reduced levels transcriptional activity com-
t55-DN3 associated subunits form TFIIIC                               pared wild type, twofold, keeping (data shown). Deletion N-terminal half t55                             twofold-lower TFIIIC-tDNA complexes formed
ticeably increased rate migration TFIIIC-tDNAGlu  3                           mutant factor. lower transcriptional activity complexes, increase migration rate ob-                              mutant form TFIIIC accounted served DNA fragment harboring B block                                deficiency DNA binding. Furthermore, deletion form tRNALeu3   gene used probe (Fig. 4A). differ-                         TFIIIC able assemble TFIIIB correct gene position,
ence migration wild-type mutant TFIIIC-                              transcripts obtained factors migrated tDNA complexes easily explained 5  difference                             level. concluded,  N-terminal half molecular mass wild-type mutant factors (30                              t55 play role stability conformation
kDa '600 kDa) reflect different conformational                             TFIIIC C-terminal domain sufficient sup-
states factor.                                                                   port t55 function TFIIIC-tDNA binding proper TFIIIB
   TFIIIC fractions purified wild-type                             assembly. mutant strains shown Western blot analysis                                  contrast deletion N-terminal domain,
contain similar amounts TFIIIC, based 95-kDa sub-                             homologous HUFp, partial deletion domain t55
unit (data shown), yield complexes obtained                         (t55-DN1) resulted unexpectedly temperature-sensitive
t55-DN3 TFIIIC fraction twofold lower                               phenotype (Fig. 3B). effect specific t55-DN1
obtained wild-type factor. result, obtained                          deletion, different partial deletion, t55-DN2, did distinct preparations t55-DN3 factor, suggested                         detectably affect cell growth 37Â°C glucose-containing  mutant form TFIIIC slightly defective DNA                                 dium. N-terminal t55 regions sequence
binding unstable purification wild-type                         similar enzymes related glycolytic pathway
factor.                                                                                 (PGM FbPase; Fig. 1), mutant strains grown     t55-DN3 factor assayed specific transcrip-                         medium containing glycerol ethanol. Cells growing glyc-
tion different tRNA genes intron                         erol medium underwent glycolysis slowly did cells reconstituted transcription presence TFIIIB                          growing glucose medium result poor uptake  3196       MANAUD ET AL.                                                                                                                     MOL. CELL. BIOL.


                                                                                            TABLE 1. vivo interaction t55 t95                                                                                                            hybrid                                                                                                                                                  b-Galactosidase
                                                                                                       Fusion proteins
                                                                                                                                                    activitya

                                                                                   GAL4(1-147)                     GAL4(768-881)-t55                     6
                                                                                   GAL4(1-147)-t95                 GAL4(768-881)                        10
                                                                                   GAL4(1-147)-t95                 GAL4(768-881)-t55                    81
                                                                                   GAL4(1-147)-TFIIIB70            GAL4(768-881)-t131                  133
                                                                                                                                                                              Nanomoles o-nitrophenyl-b-D-galactoside hydrolyzed minute mil-
                                                                                   ligram protein.



                                                                                   viously revealed interactions t131 TFIIIB70 (12)                                                                                    TFIIIB90 (45). TFC7 ORF fused DNA
                                                                                   binding domain [GAL4(1-147)] transcriptional acti-
                                                                                   vation domain [GAL4(768-881)] yeast GAL4 protein.
                                                                                   combinations t55 fusion proteins                                                                                    TFIIIB (TFIIIB70, TFIIIB90, TBP), TFIIIC (t138, t131,
                                                                                   t95, t91), TFIIIA, PolIII (C160, C128, C82, C53,
                                                                                   AC40, C34, C31, C27, AC19, ABC10a, ABC10b) comple-
   FIG. 4. DNA binding transcriptional activities t55-DN3 TFIIIC.           mentary fusion proteins assayed (2, 12, 51). Activation TFIIIC purified heparin chromatography wild-type strain (WT) mutant strain expressing C-terminal t55 (t55-DN3).  
                                                                                   lacZ reporter gene estimated b-galactosidase assays
Formation TFIIIC-DNA complexes. Factor-DNA complexes formed             selected transformants. interaction TFIIIB70
described Materials Methods incubating wild-type t55-DN3 TFIIIC       t131 (12) used reference. Significant levels DNA probes harboring tRNAGlu     3  gene B block     b-galactosidase activity detected t55 fused tRNALeu    gene, indicated. Complexes analyzed electrophoresis        3
autoradiography quantified scanning. (B) Transcription various class
                                                                                   transcriptional activation domain assayed t95
III genes t55-DN3 TFIIIC. Wild-type t55-DN3 TFIIIC incubated        complementary fusion (Table 1). observation suggested tRNA genes reconstituted transcription mixtures described Mate-     t55 t95 interacted cell. reciprocal combi-
rials Methods. different templates indicated. RNA products         nation gave lower significant levels b-galactosidase ac- isolated electrophoresis, revealed autoradiography, quantified scanning. Glu3 template, upper RNA band taken                                                                                    tivity (data shown).  investigated interaction
account, SUP4 Leu3 templates, RNA bands, corre-           t95 deletion versions t55. truncated frag-
sponding primary mature transcripts, quantified. different rel-    ments t55 shown Fig. 3A fused DNA binding
ative yields primary mature transcripts depended level maturase   transcriptional activation domain GAL4 assayed activity present heparin-purified TFIIIC fraction.
                                                                                   reciprocal t95 fusions. Deletions N-terminal domain
                                                                                   t55 did alter significantly t55-t95 interaction.                                                                                    hand, deletion C-terminal domain t55 gave
glycerol yeast cells, cells growing medium                       background b-galactosidase levels (data shown). 
taining ethanol, respiratory substrate, did undergo gly-                     sult suggested C-terminal t55 essential colysis. imagine N-terminal t55                      interaction t95. activity interferes metabolism, growth                       interaction t55 t95 confirmed vitro
N-terminal deletion mutants medium containing glyc-                      far-Western blotting experiment (24). Partially purified
erol ethanol instead glucose affected. shown                     rTFC7p subjected SDS-PAGE, transferred mem- Fig. 3B, growth t55-DN2 mutant cells glycerol-                        branes, denatured-renatured, probed 35S-labeled t95
containing medium resulted temperature-sensitive pheno-                       antibodies directed HA epitope present type observed glucose-containing medium. Fur-                      N-terminal end rTFC7p. shown Fig. 5, t95 specif-
thermore, doubling time t55-DN1 mutant cells grown                       ically bound level t55. signal obtained 30Â°C glycerol-containing medium increased                         filters incubated labeled protein (t91) fold) compared wild-type t55, t55-DN2, t55-DN3
mutant cells. Similar results obtained cells grown medium contained ethanol  ethanol plus glyc-
erol) instead glucose (data shown). cases, wild-type phenotype restored transformation mutant cells centromeric plasmid harboring wild-type TFC7 gene. verified mutant strains rho1. concluded results N-termi-
nal domain, partially deleted, impair t55 function.
Furthermore, reduced rate growth t55-DN1 mutant
cells 30Â°C thermal sensitivity t55-DN2
                                                                                       FIG. 5. t55 interacts t95. Recombinant t55, expressed HA-tagged
mutant cells observed cells grown                          hexahistidine fusion, purified E. coli cells native conditions.
glycerol ethanol instead glucose suggested potential link                  Eluted polypeptides (1 5 mg; respectively, lanes 1 2) subjected metabolic pathways PolIII transcription.                               SDS-PAGE, transferred membrane, denatured-renatured, probed                                                                                    35
   t55 interacts t95. gain insight func-                        S-labeled t95 described Materials Methods. Labeled polypeptides
                                                                                   revealed autoradiography (lanes 1 2). membrane tion 55-kDa subunit TFIIIC, used hybrid                       incubated anti-HA antibodies (lanes 3 4), immune complexes study interactions t55 com-                      visualized ECL kit. molecular masses marker polypeptides ponents PolIII cloned far. method pre-                       indicated kilodaltons.
 VOL. 18, 1998                                                                  TFC7 ENCODES 55-kDa SUBUNIT YEAST TFIIIC                                   3197




                                                                                       FIG. 7. t55 stably associated t95. Cell extracts strains expressing
                                                                                    HA-t95 wild-type t95 chromatographed heparin column 
                                                                                    scribed previously (25).   Heparin fractions eluting 200 250 mM ammo-
                                                                                    nium sulfate containing HA-t95 t55 pooled (30 ml)                                                                                     chromatographed 4-ml anti-HA column described previously
                                                                                    (25). Proteins eluted (1-ml fractions) competition synthetic HA
                                                                                    peptide (0.1 mg/ml). Protein samples (40 ml) subjected SDS-PAGE,
                                                                                    transferred nitrocellulose membrane, probed anti-HA antibodies
                                                                                    polyclonal antibodies directed t55. Immune complexes revealed                                                                                     ECL kit. Lanes: 1 (L), heparin fraction loaded anti-HA column; 2
                                                                                    (FT), flowthrough fraction; 3 7, eluted fractions. (B) Heparin fractions (1.5
                                                                                    ml) containing untagged t95 t55 chromatographed anti-HA
   FIG. 6. Elution profile TFIIIC subunits chromatography           column (0.15 ml) described  Proteins eluted batchwise (0.1-ml
heparin column.   Cell extracts wild-type strain strains expressing   fraction) competition synthetic HA peptide. Protein samples (40 ml)
HA-t91, HA-t131, HA-t138 chromatographed heparin column             analyzed Western blotting antibodies directed t55. Lanes described previously (25). Eluted fractions assayed ammonium sulfate       panel 
(1) protein (E) concentrations. DNA binding activity TFIIIC assayed gel retardation indicated hatched zone. data correspond results obtained fractions wild-type strain. Similar results obtained fractions epitope-tagged strains. (B) Heparin fractions      contrast t91, t131, t138, t55 t95 coeluted
(20 ml) subjected SDS-PAGE, proteins transferred membranes, filters incubated antibodies. Immune complexes revealed
                                                                                    lower salt concentrations (200 250 mM ammonium sul- ECL kit. Heparin fractions wild-type strain probed       fate), fractions 52 68, did contain detectable
polyclonal antibodies directed t55 (row 1) polyclonal         TFIIIC-tDNA binding activity. results suggested antibodies directed t95 (row 2) TFIIIB70 (row 6). Heparin fractions      t55 t95 exist forms: associated TFIIIC HA-t131 (row 3), HA-t138 (row 4), HA-t91 (row 5) probed anti-HA antibodies.
                                                                                    subcomplex potentially containing proteins                                                                                     TFIIIB. TFIIIB70 (Fig. 6B) TFIIIB (data shown)
                                                                                    transcriptional activities coeluted fractions 68 92,                                                                                     t55-t95 complex (fractions 52 68). similar experiments t95 used labeled probe                        order verify physical association t55 t95, interact different blotted polypeptides (t95, TBP,                      putative subcomplex prepared strain expressing TFIIIB70) (results shown).                                                      HA-tagged version t95. heparin chromatography, pro-
   Existence t55-t95 subcomplex distinct TFIIIC.                       tein fractions eluted 200 250 mM ammonium sulfate work purification TFIIIC yeast crude                           contained t55 HA-t95 pooled extracts, observed b-galactosidaseâ€“t95 fusion protein                     purified immunoaffinity chromatography 
eluted peaks heparin chromatography (12a).                        ti-HA column described previously (25). Proteins eluted 95-kDa subunit present fractions contained                          competition HA peptide subjected SDS-
tDNA binding activity TFIIIC fractions eluting                    PAGE, transferred nitrocellulose membrane, probed
lower salt concentrations contained detectable                          anti-HA antibodies polyclonal antibodies directed tDNA binding activity. decided study precisely                       t55 (Fig. 7A). expected, HA-tagged t95 bound 
elution profile different TFIIIC subunits heparin                     ti-HA column (Fig. 7A, lanes 1 2) eluted chromatography correlate presence TFIIIC subunits                         competition HA peptide (lanes 3 7). t55 factor tDNA binding activity. Extracts wild-type                     retained antibody column (Fig. 7A, lane 2) various epitope-tagged yeast strains chromatographed                        coeluted t95 (lanes 3 7). order verify heparin columns, proteins eluted ammonium                          coelution t55 t95 resulted stable association
sulfate gradient. Fractions assayed salt protein                       subunits fortuitous binding
concentrations DNA binding activity 32P-                        t55 anti-HA column, similar experiment 
labeled tDNA (Fig. 6A). Eluted proteins subjected                         formed control heparin fraction prepared wild- SDS-PAGE, transferred nitrocellulose membranes,                           type strain harboring untagged t95. shown Fig. 7B, probed polyclonal antibodies directed t55 t95.                      t95 untagged, t55  untagged t95 [results Anti-HA antibodies used reveal epitope-tagged t91,                          shown]) fully recovered flowthrough fraction (Fig.
t131, t138 subunits. shown Fig. 6B, t55, t91, t95, t131,                   7B, lane 2) detected HA-eluted fractions (lane t138 eluted fractions (76 92) containing 300 350                       3). results confirmed existence t55-t95 subcom-
mM ammonium sulfate, tDNA binding activity.                             plex include polypeptides. analyzed  3198       MANAUD ET AL.                                                                                                               MOL. CELL. BIOL.


                                                                                      significant pool free t131 subunit. contrast,                                                                                       immunopurification procedure applied HA-t95
                                                                                      crude extract, relative yields TFIIIC subunits
                                                                                      markedly modified. recoveries t131 t91
                                                                                      remained levels, t55 HA-t95
                                                                                      greatly increased, range  sixfold, respec-
                                                                                      tively. results indicated markedly                                                                                       t95 t55 subunit yeast crude extracts relative                                                                                       t131 t91 corroborated existence t55-t95
                                                                                      subcomplex yeast cells.

                                                                                                               DISCUSSION
                                                                                         Yeast TFIIIC multifunctional protein required pro-
                                                                                      moter binding, TFIIIB recruitment, chromatin antirepres-
                                                                                      sion. pursued characterization multisub-
                                                                                      unit factor report isolation essential gene,
                                                                                      named TFC7, encoding smallest subunit. appears                                                                                       polypeptide chimeric protein belongs different
                                                                                      protein complexes.
   FIG. 8. Coimmunoprecipitation TFIIIC subunits crude extracts. Im-             Based biochemical data gene cloning, munoprecipitations anti-HA antibodies performed described             established largest polypeptides, 138, 131, 95,
Materials Methods crude extracts wild-type (WT) strain strains expressing HA-tagged versions t138, t131, t95 (HA-t138, HA-
                                                                                      91 kDa, contained highly purified TFIIIC fractions t131, HA-t95, respectively). Proteins eluting synthetic peptides         subunits TFIIIC. smallest polypeptides (60 55 subjected SDS-PAGE, transferred membrane, probed succes-             kDa) consistently TFIIIC fractions
sively polyclonal antibodies directed t95, t55, t131, t91. Im-       different laboratories (5, 16, 43). Using peptide sequences
mune complexes revealed ECL kit quantified scanning. value 1 arbitrarily given amounts t95, t55, t131, t91 subunits
                                                                                      obtained gel-purified protein, identified immunoprecipitated HA-t138 crude extract used refer-            TFC7 gene encoding 55-kDa polypeptide. Polyclonal anti-
ence. left indicated molecular masses  kilodaltons) polypep-     bodies directed rTFC7p able supershift TFIIIC-
tides probed antibodies noted right. 75-kDa polypeptide             tDNA complexes, confirming presence 55-kDa
revealed anti-t91 antibodies immunologically related t91 (2).
                                                                                      polypeptide factor-tDNA complex. Like                                                                                       genes encoding components yeast PolIII transcription
                                                                                      isolated far, TFC7 essential gene.
silver staining, eluted fractions contained HA-t95                          Searches databases revealed chimeric structure t55 polypeptides (data shown).                           TFC7p. N-terminal TFC7p showed intriguing sim-
   determine t55-t95 subcomplex                              ilarities proteins unrelated transcription present crude extract confirm                      highly similar yeast hypothetical protein unknown func-
partial TFIIIC dissociation heparin chromatography,                            tion (named HUFp). hand, significant se-
immunoprecipitations performed crude extracts pre-                          quence similarities detected C-terminal pared wild-type strain strains expressing                           TFC7p. fact, coding sequences N-terminal
HA-tagged copy t138 (HA-t138), t131 (HA-t131), t95                              TFC7p HUFp located just border (HA-t95). Anti-HA antibodies used immunopurifica-                            duplication block 50 present chromosome XIV tion, bound proteins eluted competition                            chromosome XV (54). hypothesis chimeric
specific peptide antigen. Using immunopurified proteins                           structure t55 resulted fusion ancestral HA-t138, HA-t131, HA-t95 crude extracts, suc-                              transcription factor subunit (corresponding C-terminal
ceeded reconstituting transcription tRNA gene,                        t55 included duplication block) TFIIIC activity recovered similar efficiencies                        protein unknown function (encoded ances- cases (data shown). Eluted TFIIIC fractions                            tral HUF corresponding N-terminal t55).
analyzed Western blotting probed polyclonal                            hypothesis, explain intriguing sequence
tibodies directed t95, t55, t91, t131. Immune complexes                         similarities TFIIIC subunit cyanobacterial revealed chemiluminescence (Fig. 8). expected,                          protein (Syn H), supported results t55 deletion
TFIIIC subunit detected immunopurification                               mutant analysis.  C-terminal t55 performed wild-type crude extract containing HA-                            necessary interaction t95 sufficient tran-
tagged polypeptide (Fig. 8, WT). contrast, immunoprecipi-                          scription factor activity. deletion C-termi-
tation crude extracts containing HA-tagged subunit                            nal t55 lethal, mutant form TFIIIC entirely
(Fig. 8, HA-t138, HA-t131, HA-t95) resulted copu-                           deprived N-terminal half t55 (t55-DN3) supported
rification 95-, 55-, 131-, 91-kDa subunits, indicating                     normal cell growth, able bind tDNA promoter se-
association polypeptides                                     quences vitro,  bound, recruited TFIIIB produc-
   results immunopurification shown Fig. 8                         tively efficiently wild-type factor.  al-
quantified scanning. value 1 arbitrarily given                       N-terminal domain t55 dispensable t95, t55, t131, t91 subunit immunopuri-                          TFIIIC activity, partial deletion domain (t55-DN1)
fied HA-t138 crude extract used refer-                          impaired t55 function high temperature. residual
ence. shown Fig. 8, polypeptides recov-                         presence truncated N-terminal fragment inter-
ered approximately efficiencies                            fered t55 folding led defect TFIIIC assembly relative yields HA-t131 crude extract. Note                        stability.
HA-t131 overrepresented, suggesting absence                             N-terminal t55 showed sequence similarities  VOL. 18, 1998                                                   TFC7 ENCODES 55-kDa SUBUNIT YEAST TFIIIC                                 3199


different enzymes catalyze similar phosphotransfer reac-                                 ACKNOWLEDGMENTS
tions, specifically, enzymes related glycolytic path-       thank Christophe Carles FrancÂ¸oise Bouet peptide se-
way (PGM FbPase) acid phosphatase. residues             quence determination Anny Ruet help raising rabbit poly-
important catalytic activity enzymes       clonal antibodies. grateful Janine Huet Emmanuel
served t55, assayed TFIIIC rTFC7p enzymatic            Favry B0, recombinant TBP, recombinant TFIIIB70, PolIII
activity. PGM phosphatase activities detected          preparations. thank Jochen Ru   Â¨th Genevie`ve Dujardin sults shown).  partial deletions N-ter-      helpful discussions Cathy Jackson improving manuscript.
                                                                        work supported grant European Union
minal domain t55 resulted reduced growth rate 30Â°C        BIOTECH program  S.). N.M. supported fellowship
(t55-DN1) thermosensitive phenotype (t55-DN1             French Ministe lâ€™Enseignement SupeÂ´rieur et la 
t55-DN2) glycerol- ethanol-containing medium.            cherche, R  supported P.F  postdoctoral fellowship
growth defects, revealed medium contain-          Spanish Ministerio EducacioÂ´n y Cultura.
ing glycerol ethanol instead glucose, suggest possible
relationship PolIII transcription metabolic path-                                        REFERENCES
ways deserves investigated                        1. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, D. J. Lipman. 1990.
   direct interaction t55 t95 observed vitro          Basic local alignment search tool. J. Mol. Biol. 215:403â€“410. vivo agrees photo-cross-linking mapping       2. Arrebola, R., N. Manaud, S. Rozenfeld, M. C. Marsolier, O. Lefebvre, C.
                                                                         Carles, P. Thuriaux, C. Conesa,  Sentenac. 1998. t91, essential polypeptides opposite sides DNA helix,            subunit yeast transcription factor IIIC, cooperates t138 DNA vicinity block tRNA genes (5, 6). inability          binding. Mol. Cell. Biol. 18:1â€“9. alter migration tB-tDNA complexes anti-t55             3. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. 
                                                                         Smith, K. Struhl (ed.). 1994. Current protocols molecular biology.
antibodies (data shown) argues favor               John Wiley & Sons, , New York, N.Y.
localization t55 tA, TFIIIC domain binds        4. Baker, R. E., B. D. Hall. 1984. Structural features yeast tRNA genes block tRNA genes.  sequence analysis t55 did             affect transcription factor binding. EMBO J. 3:2793â€“2800.
                                                                      5. Bartholomew, B., G.  Kassavetis, B. R. Braun, E. P. Geiduschek. 1990. reveal known DNA binding motifs, attempts                 subunit structure Saccharomyces cerevisiae transcription factor IIIC
demonstrate, gel retardation assays Southwestern blot-             probed novel photocrosslinking reagent. EMBO J. 9:2197â€“2205.
ting, t55 t95 binds DNA, nonspecifically, failed      6. Bartholomew, B., G.  Kassavetis, E. P. Geiduschek. 1991. com-
                                                                         ponents Saccharomyces cerevisiae transcription factor IIIB (TFIIIB) (results shown) (44, 48). imagine              stereospecifically located upstream tRNA gene interact teraction tA block tRNA genes requires              second-largest subunit TFIIIC. Mol. Cell. Biol. 11:5181â€“5189.
association t95 t55.  tDNA binding             7. Baudin, , O. Ozier-Kalogeropoulos,  Denouel, F. Lacroute, C. Cul-
                                                                         lin. 1993. simple efficient method direct gene deletion Saccha-
activity transcriptional activation  inhibition)         romyces cerevisiae. Nucleic Acids Res. 21:3329â€“3330. associated partially purified t55-t95 subcomplex         8. Bradford, M. M. 1976. rapid sensitive method quantitation (results shown). point view, presence            microgram quantities protein utilizing principle protein-dye bind- TFIIIC components distinct complexes reminis-              ing. Anal. Biochem. 72:248â€“254.
                                                                      9. Braun, B. R., B. Bartholomew, G.  Kassavetis, E. P. Geiduschek. 1992.
cent equivalent chromatographic separation             Topography transcription factor complexes Saccharomyces cerevi- silkworm human TFIIIC distinct, complementary                 siae 5 S RNA gene. J. Mol. Biol. 228:1063â€“1077.
activities. TFIIIC activity silkworm cells separated     10. Burnol, -F., F. Margottin, J. Huet, G. Almouzni, M.-N. Prioleau, M.
                                                                         chali,  Sentenac. 1993. TFIIIC relieves repression U6 snRNA fractions, required form com-            transcription chromatin. Nature 362:475â€“477.
plex tRNA gene (41). human TFIIIC, fractions,           11. Burnol,  F., F. Margottin, P. Schultz, M. C. Marsolier, P. Oudet, 
named TFIIIC1 TFIIIC2, necessary reconsti-               Sentenac. 1993. Basal promoter enhancer elements yeast U6 snRNA
                                                                         gene. J. Mol. Biol. 233:644â€“658.
tute TFIIIC DNA binding transcriptional activities:         12. Chaussivert, N., C. Conesa, S. Shaaban,  Sentenac. 1995. Complex
TFIIIC2, multisubunit protein (33, 50, 56), binds strongly          interactions yeast TFIIIB TFIIIC. J. Biol. Chem. 270:15353â€“
itself B block tRNA genes, block binding             15358.
                                                                     12a.Conesa, C. Unpublished results.
gene transcription require TFIIIC1 (50, 55). Furthermore,            13. Conesa, C., R. N. Swanson, P. Schultz, P. Oudet,  Sentenac. 1993. TFIIIC1 chromatographically separated addi-               subunit composition, stoichiometry, phosphorylation yeast
tional activity, TFIIIC0, able partially substitute       transcription factor TFIIIC/t. J. Biol. Chem. 268:18047â€“18052.
TFIIIC1 activity (38). situation different     14. Don, R. H., P. T. Cox, B. J. Wainwright, K. Baker, J. S. Mattick. 1991.
                                                                         â€˜Touchdownâ€™ PCR circumvent spurious priming gene amplifica-
t55-t95 complex  possible associated components)             tion. Nucleic Acids Res. 19:4008.
required TFIIIC activity. existence t55-t95 com-        15. Edwards, D. R., C. L. Parfett, D. T. Denhardt. 1985. Transcriptional
plex distinct TFIIIC suggests dual role             regulation serum-induced RNAs mouse fibroblasts: equivalence                                                                          species B2 repetitive elements. Mol. Cell. Biol. 5:3280â€“3288.
subunits. complex possibly endowed regulatory           16. Gabrielsen, O. S., N. Marzouki,  Ruet,  Sentenac, P. Fromageot.
functions roles unrelated transcription.             1989. polypeptide chains yeast transcription factor t interact subcellular localization complex identification          DNA. J. Biol. Chem. 264:7505â€“7511.
                                                                     17. Gabrielsen, O. S., T. B. Oyen. 1987. requirement block associated proteins,  shed light func-         promoter tRNA gene transcription vitro depends ionic environ-
tion. uncover phenotype(s)            ment. Nucleic Acids Res. 15:5699â€“5713.
caused deletion HUFp, highly similar       18. Geiduschek, E. P., G.  Kassavetis. 1992. RNA polymerase III tran-
                                                                         scription complexes, p. 247â€“280. S. L. McKnight K. R. Yamamoto
N-terminal t55. HUFp distantly homologous               (ed.), (Transcriptional regulation, vol. 1. Cold Spring Harbor Laboratory
zymes related glycolytic pathway. similarity suggests        Press, Cold Spring Harbor, N.Y. connection cell metabolism supported      19. Gietz, R. D.,  Sugino. 1988. New yeast-Escherichia coli shuttle vectors
                                                                         constructed vitro mutagenized yeast genes lacking base pair 
altered growth phenotype t55-DN1 t55-DN2 mutant                   striction sites. Gene 74:527â€“534.
cells glycerol- ethanol-containing medium. level        20. Harlow, E., D. Lane. 1988. Antibodies: laboratory manual. Cold Spring
PolIII transcription known vary according cell              Harbor Laboratory, Cold Spring Harbor, N.Y.
growth rate human, mouse, yeast cells (15, 23, 47, 49).       21. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, S. J. Elledge. 1993.
                                                                         p21 Cdk-interacting protein Cip1 potent inhibitor G1 cyclin-
TFIIIC components play role coordinated reg-               dependent kinases. Cell 75:805â€“816.
ulation.                                                             22. Heinemeyer, W.,  Gruhler, V. Mohrle, Y. Mahe, D. H. Wolf. 1993.
